2022
Accuracy of Simulated Research Tasks by Community Hospitals Participating in a Multicenter Telemedicine Trial
Fang JL, Whyte H, Umoren R, Limjoco J, Makkar A, Yankanah R, McCoy M, Lo MD, Herrin J, Demaerschalk BM. Accuracy of Simulated Research Tasks by Community Hospitals Participating in a Multicenter Telemedicine Trial. Telemedicine Journal And E-Health 2022, 28: 1489-1495. PMID: 35167373, DOI: 10.1089/tmj.2021.0574.Peer-Reviewed Original ResearchConceptsHealth care professionalsCommunity hospitalCare professionalsStudy eligibilityClinical trialsEligibility criteriaStudy-eligible patientsSubsequent clinical trialsTelemedicine trialsTrial eligibility criteriaStandard descriptive statisticsEligible patientsNeonatal resuscitation scenarioTrial eligibilitySurvey response rateBACKGROUND/Clinical scenariosResponse rateHospitalTrialsResuscitation scenariosElectronic surveyEligibilityData elementsDescriptive statistics
2021
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
Wallach JD, Deng Y, McCoy RG, Dhruva SS, Herrin J, Berkowitz A, Polley EC, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Shah ND, Ross JS, Lyon TD. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment. JAMA Network Open 2021, 4: e2130587. PMID: 34677594, PMCID: PMC8536955, DOI: 10.1001/jamanetworkopen.2021.30587.Peer-Reviewed Original ResearchConceptsMajor adverse cardiovascular eventsSecondary end pointsMyocardial infarctionClinical trialsCardiovascular diseaseProstate cancerCardiovascular eventsEnd pointRisk of MACELarge US administrative claims databasePropensity-matched cohort studyUS administrative claims databasePropensity score-matched patientsAdverse cardiovascular eventsPrimary end pointAdministrative claims databaseProportional hazards regressionRandomized clinical trialsAdministrative claims dataTrial eligibility criteriaMedicare Advantage beneficiariesProstate cancer treatmentReal-world evidenceElectronic health recordsCardiovascular outcomes